Intrinsiqs

Is Veracyte, Inc. overvalued?

Veracyte, Inc. (VCYT) — key valuation metrics and fundamentals.

No verdict
Price
$42.58
Fair value
Current P/E
Normal P/E
Market cap
$3.40B
Dividend yield
0.0%
Return on equity
8.6%
Sector
Healthcare

See the full interactive analysis →

Fair value compares VCYT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.